Our Blog

Clear All Filters

April 22, 2021

Elias Alsbergas

Blog Post Ethics in GovernmentExecutive BranchFinancial RegulationTreasury Department

Delaware Connections Run Deep As DuPont Family's Darla Pomeroy Heads To Treasury

Darla Pomeroy, who is married to an heir to the DuPont family fortune, was just named Senior Advisor to the Office of Domestic Finance at the US Treasury. While her record does not show any familiarity with financial regulatory policy, it reveals instead a history of a powerful corporation highly influential in Delaware placing a close ally in the administration.

April 22, 2021

Press Release Executive BranchFinancial RegulationRevolving Door

Wall Street Lawyer Leading Wall Street Oversight Unsettles Allies Of Gensler

“Oh has chosen to spend over 20 years reinforcing a corrupt status quo in corporate America, in which the largest companies systematically evade democratic accountability. No one so comfortable with the breakdown in the rule of law over corporate America should be entrusted with responsibility for implementing long-overdue accountability on Wall Street.”

April 19, 2021 | The Daily Beast

Miranda Litwak

Op-Ed 2020 Election/TransitionAnti-MonopolyLarry Summers

Silicon Valley’s Favorite Fixer Aims to Stop the Rising Left

But the old guard continues to wield significant power and will be hard pressed to admit defeat, as exemplified by political strategist Bradley Tusk’s continued success. Some might recall Tusk as New York Mayor Bill De Blasio’s biggest critic. Others know him best as Silicon Valley’s favorite political fixer. Teachers’ unions probably remember him comparing them to the NRA. Tusk’s particular brand of politics—lobbying against regulation on behalf of companies he then invests in—in some ways represents the last gasp of corporate control over government that has run rampant since the Reagan era.

April 16, 2021

Fatou Ndiaye Zena Wolf

Blog Post CoronavirusExecutive BranchIntellectual PropertyRevolving Door

The Brother Of A Pharma Lobbyist Advises Biden As He Weighs Vaccine IP Waiver

Despite pushback from progressives, Ricchetti has continued to hold a powerful advisory position in the Biden White House. His background in corporate lobbying and strong ties to the pharmaceutical industry are deeply troubling signs as the Biden Administration faces enormously consequential decisions about how to end the COVID-19 pandemic.

April 15, 2021

Timi Iwayemi

Blog Post Foreign PolicyIntellectual Property

Why Is Politico's Ryan Heath Carrying Water For Big Pharma Monopolies?

The world is currently at an inflection point – Western leaders can choose to continue blocking the TRIPS waiver and lock in a cycle of dependence or empower poorer countries to develop generic vaccines and build infrastructure that will safely put the pandemic behind us. Critiques of the TRIPS waiver claim that most poor countries lack the infrastructure to carry out vaccine operations – a paternalistic view that suggests that manufacturing capacity, supply chain management, and logistics are static in nature. The sooner we act, the more time poorer countries have to begin mobilizing resources needed to make generic vaccine development possible.

April 14, 2021

Henry Burke

Blog Post 2020 Election/TransitionGovernment Capacity

Biden’s Build Back Better is Behind Schedule

On the campaign trail, Biden was reluctant to criticize any aspect of the “Obama-Biden” administration’s record. Since taking office, however, he has made perfectly clear that he is aware of, and has learned from, many of its mistakes. Having watched how an anemic stimulus package in 2009 delivered a slow, faltering recovery and political carnage, the Biden administration chose to go big with its economic response. This initial, consequential departure has earned Biden accolades and prompted a “growing narrative that he’s bolder and bigger-thinking than President Obama” (a narrative Biden reportedly loves). But while Biden may be surpassing Obama legislatively, he is lagging behind him when it comes to the pace of nominations, delaying policy implementation and preventing his administration from reaching its full potential.

April 14, 2021 | The American Prospect

Henry Burke Sion Bell

Op-Ed Government Capacity

Biden’s Budget Should Build Back Even Better

President Biden’s inaugural annual budget request, which encompasses only discretionary spending (about a third of the federal budget), is a $1.52 trillion proposed investment in the federal government. The rest of the request, to be released later this spring, will include tax reforms and mandatory spending (which includes programs like Social Security, Medicare, and Medicaid) and provide a fuller picture of the administration’s priorities.